ICU MEDICAL INC/DE Total Revenue

• ICU MEDICAL INC/DE showed a decrease of -6.3% in Total Revenue from 2024 to 2025.
• This data is from ICU MEDICAL INC/DE's annual report (Form 10-K), filed with the SEC on February 19, 2026.
• XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q3 2012: $81.41 million | Q4 2012: $82.67 million | Q1 2013: $74.30 million | Q2 2013: $78.66 million | Q3 2013: $82.82 million | Q4 2013: $77.94 million | Q1 2014: $73.23 million | Q2 2014: $78.68 million | Q3 2014: $77.46 million | Q1 2015: $81.48 million | Q2 2015: $83.78 million | Q3 2015: $86.02 million | Q1 2016: $89.86 million | Q2 2016: $96.72 million | Q3 2016: $97.11 million | Q1 2017: $247.74 million | Q2 2017: $331.51 million | Q3 2017: $343.24 million | Q3 2017: $343.24 million | Q4 2017: $370.12 million | Q1 2018: $372.03 million | Q1 2018: $372.03 million | Q2 2018: $360.46 million | Q2 2018: $360.46 million | Q3 2018: $327.17 million | Q3 2018: $327.17 million | Q4 2018: $340.38 million | Q1 2019: $330.93 million | Q1 2019: $330.93 million | Q2 2019: $312.28 million | Q2 2019: $312.28 million | Q3 2019: $307.47 million | Q3 2019: $307.47 million | Q4 2019: $315.52 million | Q1 2020: $328.61 million | Q1 2020: $328.61 million | Q2 2020: $303.38 million | Q2 2020: $303.38 million | Q3 2020: $318.57 million | Q3 2020: $318.57 million | Q4 2020: $320.45 million | Q1 2021: $318.05 million | Q2 2021: $321.68 million | Q3 2021: $336.06 million | Q1 2022: $543.12 million | Q2 2022: $561.00 million | Q3 2022: $597.86 million | Q1 2023: $568.65 million | Q2 2023: $549.31 million | Q3 2023: $553.31 million | Q1 2024: $566.66 million | Q2 2024: $596.46 million | Q3 2024: $589.13 million | Q1 2025: $604.70 million | Q2 2025: $548.87 million | Q3 2025: $536.99 million.
• Over the full 18 years of available data (2008 to 2025), ICU MEDICAL INC/DE's Total Revenue has grown by 989.9%.
• Historical annual values: Fiscal year 2025: $2.23 billion | Fiscal year 2024: $2.38 billion | Fiscal year 2023: $2.26 billion | Fiscal year 2022: $2.28 billion | Fiscal year 2021: $1.32 billion | Fiscal year 2020: $1.27 billion | Fiscal year 2019: $1.27 billion | Fiscal year 2018: $1.40 billion | Fiscal year 2017: $1.29 billion | Fiscal year 2016: $379.37 million | Fiscal year 2015: $341.67 million | Fiscal year 2014: $309.26 million | Fiscal year 2013: $313.72 million | Fiscal year 2012: $316.87 million | Fiscal year 2011: $302.20 million | Fiscal year 2010: $282.96 million | Fiscal year 2009: $228.97 million | Fiscal year 2008: $204.73 million.
• Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: August 7, 2026